Osang Healthcare Co.,Ltd (KOSDAQ: 036220)
South Korea
· Delayed Price · Currency is KRW 11,950
-240 (-1.97%)
Dec 19, 2024, 9:00 AM KST
Osang Healthcare Co.,Ltd Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2015 | 2014 - 2010 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '15 Dec 31, 2015 | 2014 - 2010 |
| Operating Revenue | 75,711 | 355,847 | 193,893 | 132,327 | 257,967 | 50,383 | Upgrade
|
| Other Revenue | 0 | - | - | -0 | - | - | Upgrade
|
| Revenue | 75,711 | 355,847 | 193,893 | 132,327 | 257,967 | 50,383 | Upgrade
|
| Revenue Growth (YoY) | -80.43% | 83.53% | 46.53% | -48.70% | 412.01% | -8.53% | Upgrade
|
| Cost of Revenue | 50,290 | 134,739 | 95,860 | 84,710 | 67,605 | 30,684 | Upgrade
|
| Gross Profit | 25,420 | 221,108 | 98,033 | 47,617 | 190,362 | 19,700 | Upgrade
|
| Selling, General & Admin | 22,755 | 56,067 | 32,776 | 22,372 | 19,725 | 12,191 | Upgrade
|
| Research & Development | 20,929 | 16,638 | 12,107 | 9,281 | 6,487 | 5,774 | Upgrade
|
| Other Operating Expenses | 925.64 | 904.7 | 737.64 | 638.45 | 510.53 | 611.99 | Upgrade
|
| Operating Expenses | 49,550 | 78,768 | 48,778 | 54,724 | 29,682 | 36,031 | Upgrade
|
| Operating Income | -24,130 | 142,339 | 49,255 | -7,106 | 160,680 | -16,331 | Upgrade
|
| Interest Expense | -21.81 | -58.94 | -25.13 | -15.38 | -351.29 | -1,217 | Upgrade
|
| Interest & Investment Income | 2,365 | 3,397 | 677.49 | 831.5 | 1,007 | 104.25 | Upgrade
|
| Earnings From Equity Investments | -1,671 | 925.89 | 259.8 | 913.21 | 733.43 | - | Upgrade
|
| Currency Exchange Gain (Loss) | -350.93 | 7,649 | 2,132 | 4,054 | -6,621 | 136.62 | Upgrade
|
| Other Non Operating Income (Expenses) | 117.71 | -62.34 | 309.81 | 35.31 | 10.71 | 10,887 | Upgrade
|
| EBT Excluding Unusual Items | -23,691 | 154,190 | 52,609 | -1,287 | 155,459 | -6,421 | Upgrade
|
| Gain (Loss) on Sale of Investments | 3,482 | -104.99 | -984.88 | 1,321 | 60.59 | -868.23 | Upgrade
|
| Gain (Loss) on Sale of Assets | -1,651 | -1,640 | 216.07 | 5.33 | -152.58 | - | Upgrade
|
| Asset Writedown | -20.96 | -9.69 | -0.07 | -0.68 | -10.94 | - | Upgrade
|
| Pretax Income | -21,881 | 152,435 | 51,840 | 38.06 | 155,356 | -7,289 | Upgrade
|
| Income Tax Expense | -7,891 | 35,770 | 11,179 | -1,435 | 30,360 | 1,118 | Upgrade
|
| Earnings From Continuing Operations | -13,990 | 116,665 | 40,661 | 1,473 | 124,996 | -8,407 | Upgrade
|
| Minority Interest in Earnings | 21.88 | -228.91 | -13.83 | -12.71 | - | - | Upgrade
|
| Net Income | -13,968 | 116,436 | 40,647 | 1,460 | 124,996 | -8,407 | Upgrade
|
| Net Income to Common | -13,968 | 116,436 | 40,647 | 1,460 | 124,996 | -8,407 | Upgrade
|
| Net Income Growth | - | 186.46% | 2683.22% | -98.83% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 13 | 13 | 13 | 12 | 12 | 8 | Upgrade
|
| Shares Outstanding (Diluted) | 13 | 13 | 13 | 12 | 13 | 8 | Upgrade
|
| Shares Change (YoY) | -3.81% | 1.69% | 4.37% | -7.21% | 67.60% | -0.70% | Upgrade
|
| EPS (Basic) | -1097.07 | 9148.50 | 3244.90 | 118.75 | 10189.64 | -1063.00 | Upgrade
|
| EPS (Diluted) | -1097.07 | 8921.00 | 3168.00 | 118.75 | 9610.20 | -1063.00 | Upgrade
|
| EPS Growth | - | 181.60% | 2567.89% | -98.76% | - | - | Upgrade
|
| Free Cash Flow | -82,101 | 116,893 | 30,651 | 1,768 | 93,340 | -1,341 | Upgrade
|
| Free Cash Flow Per Share | -6448.30 | 8955.92 | 2387.99 | 143.73 | 7041.88 | -169.57 | Upgrade
|
| Dividend Per Share | 2000.000 | 2000.000 | - | - | 2000.000 | - | Upgrade
|
| Gross Margin | 33.58% | 62.14% | 50.56% | 35.98% | 73.79% | 39.10% | Upgrade
|
| Operating Margin | -31.87% | 40.00% | 25.40% | -5.37% | 62.29% | -32.41% | Upgrade
|
| Profit Margin | -18.45% | 32.72% | 20.96% | 1.10% | 48.45% | -16.69% | Upgrade
|
| Free Cash Flow Margin | -108.44% | 32.85% | 15.81% | 1.34% | 36.18% | -2.66% | Upgrade
|
| EBITDA | -17,502 | 148,675 | 54,668 | -3,150 | 163,354 | -13,837 | Upgrade
|
| EBITDA Margin | -23.12% | 41.78% | 28.19% | -2.38% | 63.32% | -27.46% | Upgrade
|
| D&A For EBITDA | 6,628 | 6,335 | 5,413 | 3,956 | 2,673 | 2,494 | Upgrade
|
| EBIT | -24,130 | 142,339 | 49,255 | -7,106 | 160,680 | -16,331 | Upgrade
|
| EBIT Margin | -31.87% | 40.00% | 25.40% | -5.37% | 62.29% | -32.41% | Upgrade
|
| Effective Tax Rate | - | 23.47% | 21.56% | - | 19.54% | - | Upgrade
|
| Advertising Expenses | - | 309.9 | 325.43 | 332.29 | 105.13 | 1,804 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.